EBS vs IT · rev $1.04B vs P/E 16, rev $6.27B
Emergent Biosolutions Inc (EBS) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
EBS currently screens at market cap $416.4M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the EBS and IT stock pages for the full models.
Not investment advice.